Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Paediatrics
  4. Back
  5. Emergency Medicine (Paediatric)
  6. Pneumonia, community acquired guideline in children (230)
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Pneumonia, community acquired guideline in children (230)

Warning

Objectives

Provide a guideline for the assessment, investigation and management of children with a community acquired pneumonia.

Scope

Could this child have bronchiolitis, viral induced wheeze, croup, pertussis or an upper respiratory tract infection?  Then this guideline does not apply

This guideline is based on children without existing underlying pathology (e.g. cystic fibrosis see CF guidelines). Have a low threshold for observation, investigation, treatment and admission in children with co morbidities. 

Audience

Medical and nursing staff involved in the care of acutely unwell children. 

November 2023: This guidance is currently under review as it has gone beyond the standard review date. It reflects best practice at the time of authorship / last review and remains safe for use. If there are any concerns regarding the content then please consult with senior clinical staff to confirm.

Community Acquired Pneumonia (CAP) can be defined clinically as the presence of signs and symptoms acute infection in the pulmonary parenchyma in a previously healthy child due to an infection which has been acquired outside hospital

The following guideline is almost completely taken from the updated (2011) British Thoracic Society Guideline on community acquired pneumonia in children

Children are regularly brought by their parents or are referred by primary care practitioners with symptoms and signs suggestive of pneumonia. Decisions we have to make include.

  • What features of history and examination suggest pneumonia?
  • What investigations, if any, are required?
  • Which patients need admitted/ referred PICU?
  • Who should get antibiotics and what sort should be prescribed?
  • What complications of pneumonia should we be looking out for?
  • What follow up if any should we recommend?

History and clinical features

History and clinical features

The clinical features of CAP vary with the age of the child and tend not be very specific for diagnosis.

  • Absence of rhino rhea or sore throat together with any combination of the following is more suggestive of pneumonia
    • fever
    • tachypnoea
    • increased work of breathing 
    • cough
    • chest pain 
    • Focal chest signs: crepitations or bronchial breathing
  • Age is a good predictor of the likely pathogens:
    • Viruses alone are found as a cause in younger children in up to 50%.
    • In older children, when a bacterial cause is found, it is most commonly strep pneumoniae followed by mycoplasma.                
  • Bacterial pneumonia should be considered in children when there is persistent or repetitive fever >38.5oC together with chest recession and a raised respiratory rate.
  • A persistent, hacking cough can be seen with Mycoplasma
  • Abrupt onset of myalgias, arthralgia, headache, and fever suggest influenza or mycoplasm
  • Is there any TB contact? Either direct contact with known cases or visitors from or travel to endemic areas. See appendix A.

Investigations

X-Ray

  • Chest radiography should not be considered a routine investigation in children thought to have community acquired pneumonia who are well enough to be discharged.
  • Severe symptoms in children requiring admission would merit a chest x-ray
  • Suspicion of complications such as pleural effusion would also be an indication for x-ray.
  • A lateral x-ray should not be performed routinely.

Other investigations

  • Acute phase reactants are not of clinical utility in distinguishing viral from bacterial infections and should not be tested routinely.
  • C reactive protein is not useful in the management of uncomplicated pneumonia and should not be measured routinely.
  • Microbiological investigations should not be considered routinely in those with milder disease or those fit for discharge.
  • Microbiological diagnosis should be attempted in children with severe pneumonia sufficient to require paediatric intensive care admission, or those with complications of CAP.
  • Microbiological methods used should include:
    • Blood culture. Blood culture positivity is uncommon (<10%) of those with pneumococcal pneumonia.
    • Nasopharyngeal secretions and/or nasal swabs for viral detection by PCR and/or immunofluorescence.
    • Acute and convalescent serology for respiratory viruses, Mycoplasma and Chlamydia. 

Severity assessment

  • Auscultation revealing absent breath sounds with a dull percussion note should raise the possibility of a pneumonia complicated by effusion and should trigger a cxr.

  • Patients whose oxygen saturation is 92 % while breathing air should be treated with oxygen given by nasal cannulae, or face mask to maintain oxygen saturation >92%

infants

Mild to moderate

Severe

 

Temperature <38.5 C

Temperature >38.5 C

 

Respiratory rate <50 breaths/min

Respiratory rate >70 breaths/min

 

Mild recession

Intermittent apnoea

Grunting respiration

 

Taking full feeds

Not feeding

 

 

Tachycardia

Capillary refill time >2 s

Older children

Mild to moderate

Severe

 

Temperature <38.5 C

Temperature >38.5 C

 

Respiratory rate

<50 breaths/min

Severe difficulty in breathing 

 

Mild breathlessness

Signs of dehydration

Tachycardia

Capillary refill time >2 s 

 

No vomiting

Sa02 < 92% or cyanosed

 

What are the indications for transfer to intensive care?

  • When the pneumonia is so severe that the child is developing severe respiratory failure requiring assisted ventilation.
  • A pneumonia complicated by septicaemia. 

 

Key features that suggest a child requires transfer include: 

  • Failure to maintain oxygen saturation >92% in high flow oxygen 

  • Shock.

  • Rising respiratory and pulse rate with clinical evidence of severe respiratory distress and exhaustion, with or without a raised arterial carbon dioxide tension.

  • Recurrent apnoea or slow irregular breathing. 

Management

Management

  • Nasogastric tubes may compromise breathing. If use cannot be avoided, the smallest tube should be passed down the smallest nostril.
  • Chest physiotherapy is not beneficial and should not be performed in children with pneumonia

Antibiotic management

  • All children with a clinical diagnosis of pneumonia should receive antibiotics as bacterial and viral pneumonia cannot reliably be distinguished from each other.
  • Children aged <2 years presenting with mild symptoms of lower respiratory tract infection do not usually have pneumonia and need not be treated with antibiotics but should be reviewed if symptoms persist. A history of conjugate pneumococcal vaccination is reassuring. 
  • In pneumonia associated with influenza, co-amoxiclav is recommended (may be staph).
  • Antibiotics administered orally are safe and effective for children presenting with even severe CAP and are recommended.

 

AGE

 

 

< 5

Amoxicillin for 7 days 

Azithromycin for 3 days if true penicillin allergy

>5

Azithromycin for 3 days

 

  • Recommended IV antibiotics for CAP
    cefuroxime, if septic add gentamicin(if suspicious of atypical pneumonia add clarithromycin).
  • Intravenous antibiotics should be used in the treatment of pneumonia in children when the child is unable to tolerate oral fluids or absorb oral antibiotics (e.g. because of vomiting) or presents with signs of septicaemia or complicated pneumonia. 

Advice for a child with CAP who does not require hospital admission comprises advising parents and carers about:

  • Management of fever
    • use of antipyretics
    • Avoidance of tepid sponging
  • Preventing dehydration
    • identifying signs of deterioration
    • identifying signs of other serious illness
  • How to access further healthcare.

(Over-the-counter remedies:  No over-the-counter cough medicines have been found to be effective in pneumonia)

Complications

Children with CAP in the community who attended the department should be reassessed if they are not responding to treatment, e.g. persistence of fever 48hours after initiation of treatment, increased work of breathing or if the child is becoming distressed or agitated. 

Pleural Effusions/Empyema

May develop in 1% of patients with CAP and incidence of empyema is increasing.  A clinician should consider empyema when a child presents with a persistent fever beyond 7 days  or a persisting fever despite adequate antibiotic treatment for 48hrs. A chest xray will show fluid in the pleural space +/- ultrasound and respiratory team referral to decide on if and mode of pleural drainage employed.

Lung Abscess

Rare but important complication may be suggested by CXR. Certain groups of patients such as those with congenital cysts, sequestrations, bronchiectasis, neurological disorders and Immunodeficiency are thought to be more prone. Referral to respiratory team and CT chest will be necessary.

Septicaemia and metastatic infection

Children may have pneumonia but also show signs of sepsis (these children usually need PICU)

Metastatic infection can rarely occur as a result of the septicaemia associated with pneumonia. e.g. osteomyelitis or septic arthritis should be considered, particularly withS aureus infections.

Haemolytic uraemic syndrome

S pneumoniae is a rare cause of haemolytic uraemic syndrome. Will be suggested by pallor, severe anaemia and anuria.

Complications associated with Mycoplasma pneumonia

Various complications in association with M pneumoniae have been reported.

Rashes are common, the Stevens Johnson syndrome occurs rarely, and haemolytic anaemia, polyarthritis, pancreatitis, hepatitis, pericarditis, myocarditis and neurological complications including encephalitis, aseptic meningitis, transverse myelitis and acute psychosis have all been reported.

Follow up

Follow-up radiography is not required in those who were previously healthy and who are recovering well, but should be considered in those with a round pneumonia, collapse on CXR if it was done or persisting symptoms/signs are present.

Appendix A: pulmonary tuberculosis

  • Pulmonary Tuberculosis is considered separately from community acquired pneumonia. It is a rare presentation to the department. 
  • A  study in 2005  comparing children who had pulmonary TB with those who had persistant (>2/52) respiratory symptoms presenting to a healthcare facility showed :
    • Persistent, non-remitting coughwas reported in 15/16 (93.8%) children with tuberculosis and in 2/135 (1.5%) children without tuberculosis, indicating a specificity of 98.5% (135/137).
    • Persistent fatigue of recent onsetwas also sensitive (13/16, 81.3%) and specific (134/135, 99.3%).
    • Persistent fever and/or chest painwere exclusively reported in children with tuberculosis, but were present in only 4/16 (25.0%) children without tuberculosis

Around 50% of children with TB have been reported to have no symptoms

  • Suspicion should also be raised in a patient with  weight loss , cough and  fever who does not respond to antibiotic therapy for acute respiratory disease
  • Contact with known cases or visitors from or travel to endemic areas in children with respiratory symptoms and or signs would be an indication for a CXR.
  • Remember to ask about and check for marks of BCG vaccination

Any patient with X-ray changes suggestive of TB should be referred to the TB clinic the next week for further investigation.

Contact Sandra Stewart via Emailsandra.stewart@ggc.scot.nhs.uk and alsocopy the Email to Dr James Paton who runs the clinic pleaseJames.Paton@glasgow.ac.uk.

Let them know the patients details, date of attendance and reason for referral. They will usually organise the exact time and date of attendance and notify the family. If necessarily they can involve one of the TB nurses. The appointment will usually be at the next clinic (i.e. within one week).

Editorial Information

Last reviewed: 30/11/2017

Next review date: 30/04/2024

Author(s): Steve Foster / Vincent Choudhery.

Version: 3

Approved By: Clinical Effectiveness

Reviewer name(s): Paediatric Clinical Effectiveness & Risk Committee .

Document Id: 230